From Zacks Investment Research: 2025-04-01 14:26:00

GE HealthCare Technologies Inc. completed the acquisition of the remaining 50% stake in Nihon Medi-Physics Co., Ltd from Sumitomo Chemical, giving it full ownership, enhancing patient access to radiopharmaceuticals in Japan. The move is expected to strengthen GE HealthCare’s Pharmaceutical Diagnostics segment. GE HealthCare’s market capitalization is $36.91 billion, with an earnings yield of 5.8%. The global radiopharmaceuticals market is expected to reach $25.33 billion by 2031. GE HealthCare reported an uptick in its top line in Q4 2024, driven by its Pharmaceutical Diagnostics business. Shares of GEHC have lost 8.5% in the past year.



Read more at Zacks Investment Research: GEHC Stock Gains Following Buyout Completion to Boost Its PDx Arm – April 1, 2025